Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 24, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 26 October 2026 - 15:20

Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 24, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/bavencio

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters